Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05176470 |
|---|---|
| Brief Title: | Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients |
| First Submitted : | December 17, 2021 |
| First Submitted that Met QC Criteria : | December 17, 2021 |
| First Posted : | January 4, 2022 |
| Last Update Submitted that Met QC Criteria : | March 6, 2024 |
| Last Update Posted : | March 7, 2024 |